Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / [A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence].

< BACK TO ARCHIVE


2020


Zh Nevrol Psikhiatr Im S S Korsakova


http://www.ncbi.nlm.nih.gov/pubmed/32105267?dopt=Abstract


120


1

[A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence].

Authors

[A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence].
Krupitsky EM, Rybakova KV, Skurat EP, Semenova NV, Neznanov NG
Zh Nevrol Psikhiatr Im S S Korsakova. 2020; 120(1):33-43.
PMID: 32105267.

Abstract

To study the efficacy of pregabalin for relapse prevention and reduction of drinking in patients with alcohol dependence.
Read This Paper